$
56.070
-1.820(-3.140%)
  • Overview
  • Forecast
  • Valuation
Line
Line
|
Candle
Candle
1D
5D
1M
3M
6M
YTD
1Y
5Y
High
58.830
Open
57.645
VWAP
56.88
Vol
16.33M
Mkt Cap
94.55B
Low
55.810
Amount
929.03M
EV/EBITDA(TTM)
10.26
Total Shares
1.69B
EV
123.32B
EV/OCF(TTM)
14.09
P/S(TTM)
5.04

Altria Group, Inc. is a holding company, which provides a portfolio of tobacco products for United States tobacco consumers aged 21+. Its segments include smokeable products, oral tobacco products, and all other. The smokeable products segment includ...Show More

Market Estimates

Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2025Q1
FY2025Q2
FY2025Q3
4.62B
-2.12%
1.192
+3.68%
5.23B
-0.95%
1.382
+5.49%
5.30B
-0.74%
1.443
+4.6%
Estimates Revision
The market is revisingDownwardthe revenue expectations for Altria Group, Inc. (MO) for FY2025, with the revenue forecasts being adjusted by -0.14%over the past three months. During the same period, the stock price has changed by7.64%.
Revenue Estimates for FY2025
Revise Downward
down Image
-0.14%
In Past 3 Month
EPS Estimates for FY2025
Revise Downward
down Image
-0.22%
In Past 3 Month
Stock Price
Go Up
up Image
+7.64%
In Past 3 Month
7 Analyst Rating
down Image
-1.02% Downside
Wall Street analysts forecast MO stock price to fallover the next 12 months. According to Wall Street analysts, the average 1-year price target for MO is 55.50USD with a low forecast of46.00USD and a high forecast of61.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
3 Buy
3 Hold
1 Sell
Moderate Buy
down Image
-1.02% Downside
Current: 56.070
sliders
Low
46.00
Averages
55.50
High
61.00
UBS
Faham Baig
Strong Sell
Maintains
$42 → $46
2025-04-01
New
Reason
UBS analyst Faham Baig raised the firm's price target on Altria Group to $46 from $42 and keeps a Sell rating on the shares. Altria's earnings algorithm is becoming challenging, the analyst tells investors in a research note.
Morgan Stanley
Eric Serotta
Hold
Maintains
$54 → $53
2025-01-31
Reason
Morgan Stanley lowered the firm's price target on Altria Group (MO) to $53 from $54 and keeps an Equal Weight rating on the shares. Shares closed down about 2% following Altria's slight Q4 EPS beat, soft 2025 guidance, and the unfavorable NJOY patent litigation ruling, the analyst noted. The firm cites continued elevated Smokable volume declines and a limited reduced-risk portfolio, exacerbated by the NJOY litigation loss, offset by Altria's "solid financial flexibility," for its Equal Weight rating, adding that it prefer Philip Morris International (PM) in tobacco with an Overweight rating
Morgan Stanley
Eric Serotta
Hold
Initiates
$54
2025-01-16
Reason
Morgan Stanley initiated coverage of Altria Group with an Equal Weight rating and $54 price target. The firm sees a balanced risk/reward following the stock's 25% gain in the last 12 months. Altria faces elevated smokable volume declines and a limited reduced-risk portfolio, but has "solid financial flexibility," the analyst tells investors in a research note.
B of A Securities
Lisa Lewandowski
Hold
to
Strong Buy
Upgrades
$55 → $65
2024-12-06
Reason
BofA analyst Lisa Lewandowski upgraded Altria Group to Buy from Neutral with a price target of $65, up from $55.
Barclays
Gaurav Jain
Sell
Maintains
$45 → $46
2024-11-06
Reason
Barclays analyst Gaurav Jain raised the firm's price target on Altria Group to $46 from $45 and keeps an Underweight rating on the shares. In a tobacco bull market, Altria is the worst positioned tobacco company, the analyst tells investors in a research note. The firm expects worsening cigarette market share losses.
Stifel
Matthew Smith
Strong Buy
Maintains
$54 → $60
2024-11-01
Reason
Stifel raised the firm's price target on Altria Group to $60 from $54 and keeps a Buy rating on the shares. Due to a robust profit performance in the Smokeable business, which benefited from some inventory movements that were more favorable than anticipated, Altria reported a stronger third quarter business performance than the firm expected. While inventory contributed to the beat in EPS this quarter, the stronger than anticipated profitability of the Smokeable business was reassuring as the company lapped stepped up investment levels in the prior year, says the firm, which adds that remains "confident" in the company's ability to achieve its medium term guidance with a new $600M cost savings plan providing fuel for reinvestment behind smoke-free products.
Deutsche Bank
Gerry Gallagher
Strong Buy
Maintains
$52 → $60
2024-11-01
Reason
Deutsche Bank raised the firm's price target on Altria Group to $60 from $52 and keeps a Buy rating on the shares. The company's Q3 results confirmed an acceleration in growth, the analyst tells investors in a research note.
B of A Securities
Lisa Lewandowski
Hold
Maintains
$57 → $53
2024-10-15
Reason
BofA analyst Lisa Lewandowski lowered the firm's price target on Altria Group to $53 from $57 and keeps a Neutral rating on the shares. Scanner data for the 12 weeks ending September 21 suggested continued cigarette/moist smokeless volume weakness, largely offset by strong price/mix and vapor/oral nicotine growth, says the analyst, who trimmed the firm's target citing modest staples softness since the start of Q3.
Citigroup
Adam Spielman
Hold
Maintains
$45 → $48
2024-10-08
Reason
Citi raised the firm's price target on Altria Group to $48 from $44.50 and keeps a Neutral rating on the shares. The ongoing challenging backdrop for combustibles is likely to weigh on the company's Q3 delivery, the analyst tells investors in a research note. The firm trimmed its Q3 U.S. combustible volume estimates, leaving it below consensus, but increased the price target to reflect the "market rotation towards defensives." Citi also opened a "90-day negative catalyst watch" on shares of Altria Group. Although management will likely reiterate the company's fiscal year guidance metrics at the Q3 print, the "lackluster" quarter combined with the strong overall performance of the stock through Q3 means that "in the absence of another major rotation towards defensives, we expect the shares may drift back in the coming weeks," the firm writes.
Barclays
Gaurav Jain
Sell
Maintains
$43 → $45
2024-09-09
Reason

Valuation Metrics

The current forward P/E ratio for Altria Group Inc(MO.N) is 10.62, compared to its 5-year average forward P/E of 9.45. For a more detailed relative valuation and DCF analysis to assess Altria Group Inc 's fair value, click here.

Forward PE

StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
Overvalued
5Y Average PE
9.45
Current PE
10.62
Overvalued PE
10.31
Undervalued PE
8.59

Forward EV/EBITDA

StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
Overvalued
5Y Average EV/EBITDA
8.67
Current EV/EBITDA
9.49
Overvalued EV/EBITDA
9.26
Undervalued EV/EBITDA
8.08

Forward PS

StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
Strongly Overvalued
5Y Average PS
3.98
Current PS
4.83
Overvalued PS
4.36
Undervalued PS
3.60

Financials

Annual
Quarterly
FY2024Q4
YoY :
+1.63%
5.11B
Total Revenue
FY2024Q4
YoY :
+4.91%
2.93B
Operating Profit
FY2024Q4
YoY :
+47.52%
3.04B
Net Income after Tax
FY2024Q4
YoY :
+54.31%
1.79
EPS - Diluted
FY2024Q4
YoY :
+3.75%
3.29B
Free Cash Flow
FY2024Q4
YoY :
+2.36%
70.58
Gross Profit Margin - %
FY2024Q4
YoY :
+45.17%
59.52
Net Margin - %
FY2024Q4
YoY :
+35.76%
53.61
ROIC

Trading Trends

Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
988.4K
USD
1
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
0-3
Months
0.0
Volume
0
3-6
Months
110.8K
Volume
6
6-9
Months
0.0
Volume
0
0-12
Months
143.9K
Volume
16
Bought
0-3
0
0.0
Volume
Months
3-6
3
6.4K
Volume
Months
6-9
0
0.0
Volume
Months
0-12
9
15.1K
Volume
Months
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
8.0K
USD
1
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months

MO News & Events

Events Timeline
2025-04-03 (ET)
2025-04-03
06:28:31
U.S. tariffs should be 'manageable' for global tobacco companies, says UBS
select
2025-02-19 (ET)
2025-02-19
07:18:09
Altria Group backs FY25 adjusted EPS view $5.22-$5.37, consensus $5.34
select
2025-01-30 (ET)
2025-01-30
11:01:02
Altria guidance and NJOY ruling to weigh on shares, says Citi
select
2025-01-30
10:54:58
ITC agrees with Juul patent claims against Altria's NJOY
select
2025-01-30
10:51:58
Altria Group announces new $1B share repurchase program
select
2025-01-30
06:06:42
Altria Group sees FY25 adjusted EPS $5.22-$5.37, consensus $5.35
select
2025-01-30
06:04:46
Altria Group reports Q4 adjusted EPS $1.29, consensus $1.28
select
2025-01-26 (ET)
2025-01-26
07:57:37
Menthol ban withdrawal 'significant positive' for Altria and BAT, says Citi
select
2025-01-24 (ET)
2025-01-24
08:54:44
Trump administration withdraws FDA ban on menthol cigarettes
select
link
2025-01-16 (ET)
2025-01-16
11:32:17
FDA authorizes marketing of 20 Zyn nicotine pouch products
select
link
2024-12-11 (ET)
2024-12-11
10:43:36
FDA seeks White House approval to cut nicotine levels in cigarettes, NYT says
select
link
News
4.0
09:35 AMSeekingAlpha
Notable analyst calls this week: Altria, Nvidia and Paramount stocks among top picks
2.0
04-04WSJ
The Score: Nike, Apple, Stellantis and More Stocks That Defined the Week
8.0
04-04Benzinga
Sit Out Market Drama With These 3 Dividend Funds
8.0
04-04MarketWatch
Trump Tariffs are rocking the markets, but investors are seeking refuge in these dividend names
6.5
04-04MarketWatch
Don’t buy the dip, Bill Gross warns investors. He likes three stocks for now.
6.5
04-03Benzinga
Man With $30K To Deploy Wants Dividends For Life – 'Even If It's Just Enough To Pay For A Yearly Vacation Here Or There,' Reddit Reacts
7.0
04-02SeekingAlpha
Supreme Court rules in favor of FDA in case over flavored vaping products
4.0
04-02Benzinga
Wall Street's Most Accurate Analysts Give Their Take On 3 Defensive Stocks With Over 6% Dividend Yields
3.0
04-02TipRanks
SCHD ETF News, 4/2/2025
6.5
04-01MarketWatch
These 2 ETF strategies can lower your risk during this period of stock-market uncertainty
6.0
04-01SeekingAlpha
Altria is downgraded by Deutsche Bank due to near-term headwinds
2.0
04-01TipRanks
VOO ETF News, 4/1/2025
4.5
04-01NASDAQ.COM
Wednesday Sector Laggards: Transportation Services, Cigarettes & Tobacco Stocks
4.5
04-01NASDAQ.COM
Wednesday Sector Laggards: Consumer Products, Energy
8.0
04-01NASDAQ.COM
Notable Wednesday Option Activity: DDOG, ANF, MO
8.0
04-01NASDAQ.COM
Altria vs. Eli Lilly: What's the Better Stock for Dividend Investors?
4.5
04-01NASDAQ.COM
After Hours Most Active for Apr 1, 2025 : MO, NVDA, JNJ, TLT, EXC, NU, HOPE, AMZN, SRE, AAPL, CLF, BKD
4.5
03-31NASDAQ.COM
Monday Sector Leaders: Cigarettes & Tobacco, Water Utilities
6.5
03-29Yahoo Finance
3 Reasons to Buy Altria Stock Like There's No Tomorrow
4.5
03-29Yahoo Finance
Nicotine's Future Looks to Be Smoke-Free -- But Ultra-High-Yield Altria Is Falling Behind

FAQ

arrow icon

What is Altria Group Inc (MO) stock price today?

The current price of MO is 56.07 USD — it hasdecreased-3.14 % in the last trading day.

arrow icon

What is Altria Group Inc (MO)'s business?

arrow icon

What is the price predicton of MO Stock?

arrow icon

What is Altria Group Inc (MO)'s revenue for the last quarter?

arrow icon

What is Altria Group Inc (MO)'s earnings per share (EPS) for the last quarter?

arrow icon

What changes have occurred in the market's expectations for Altria Group Inc (MO)'s fundamentals?

arrow icon

How many employees does Altria Group Inc (MO). have?

arrow icon

What is Altria Group Inc (MO) market cap?